維立志博-B Stock Chart

維立志博-B (HKEX) · Health Technology. stock live price and technical analysis view. Follow HKEX data on Alerta Chart.

Checking data access...

About 維立志博-B

HKEX
Market Cap
HK$12.04B
52W Range
HK$44.72HK$97.5
Shares Out.
198.89M
Sector
Health Technology
Industry
Biotechnology

Nanjing Leads Biolabs Co., Ltd. operates as a pharmaceutical company. It engages in the research, development and commercialization of novel antibody drugs. The firm is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of innovative therapies, focusing on addressing diseases that cannot be treated by existing therapies represented by PD-1/PD-L1 antibodies, in order to meet the unmet medical needs in China and around the world in tumors, autoimmune diseases and other major diseases. The company was founded by Xiao Qiang Kang and Shou Peng Lai on November 27, 2012 and is headquartered in Nanjing, China.

www.leadsbiolabs.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
9887.HK (9887.HK) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart